Increase in shares and capital through exercise of stock acquisition rights
First written in FY2022-Q3. 8 of 9 entries say "Advanced", first in FY2022. Latest entry: FY2025.
103 other companies' latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「Issuance of new shares (exercise of stock acquisition rights) 3,740 shares」
Share issuance through exercise of stock acquisition rights continued in FY2025, increasing issued shares from 3,618,928 to 3,622,668. - FY2025AdvancedAnnual report
「1 October 2024–30 September 2025 (Note) 5 3,740 3,622,668 935 54,567 935 54,567」
Exercise of stock acquisition rights increased shares by 3,740 and capital stock and capital reserves by ¥935,000 each during the fiscal year. - FY2024AdvancedAnnual report
「1 October 2023–30 September 2024 (Note) 8 608,650 3,618,928 2,607 53,632 2,607 53,632」
During the fiscal year, shares increased by 10,250 through exercise of stock acquisition rights and by 598,400 through the share exchange with Cellpro Japan. - FY2024-Q2AdvancedAnnual report
「Exercise of stock acquisition rights on 25 March 2024 increased total issued shares by 10,000, capital stock by ¥2.500 million and capital reserves by ¥2.500 million.」
Exercise of stock acquisition rights increased shares by 10,000 and capital stock and capital reserves by ¥2.500 million each. A further 598,400 shares were issued through the share exchange with Cellpro Japan. - FY2024-Q1AdvancedAnnual report
「1 October 2023–31 December 2023 (Note) 250 3,010,528 107 51,132 107 51,132 (Note) Increase due to exercise of stock acquisition rights.」
Exercise of stock acquisition rights increased shares by 250 and capital stock and capital reserves by ¥107,000 each during the first quarter. - FY2023AdvancedAnnual report
「1 October 2022–30 September 2023 (Note 12) 4,100 3,010,278 1,025 51,025 1,025 51,025」
Exercise of stock acquisition rights increased shares by 4,100 and capital stock and capital reserves by ¥1.025 million each during the fiscal year. - FY2023-Q3AdvancedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
Exercise of stock acquisition rights increased shares by 2,500 and capital stock and capital reserves by ¥625,000 each between 1 April and 30 June 2023. - FY2022AdvancedAnnual report
「Issuance of new shares (exercise of stock acquisition rights) 5,000 shares」
Exercise of stock acquisition rights resulted in 5,000 new shares and increased capital stock and capital reserves by ¥1.250 million each. - FY2022-Q3First statedAnnual report
「1 April 2022–30 June 2022 (Note) 5,000 3,006,178 1,250 572,064 1,250 564,064」
Exercise of stock acquisition rights increased shares by 5,000 and increased capital stock and capital reserves by ¥1.250 million each during the third-quarter accounting period.